Month: March 2024

OTTAWA, March 27, 2024 (GLOBE NEWSWIRE) — Calian Group Ltd. (TSX: CGY), a diverse products and services company providing innovative healthcare, communications, learning and cybersecurity solutions, is pleased to appoint Valérie Travain-Milone as President, Advanced Technologies (AT). Travain-Milone brings extensive leadership experience across GNSS, telecom, space, cybersecurity and digital services. Known for her purpose-driven approach and passion for technology, she has consistently nurtured teams towards success and growth. Holding an MBA in aerospace and with global experience in the Pacific, Europe and North America, her visionary leadership in per past role as CEO of Atos Canada fuelled the company’s expansion and accelerated revenue growth. “I am thrilled to welcome Valérie to the Calian team. With her global perspective...

BEIJING, March 27, 2024 (GLOBE NEWSWIRE) — Li Auto Inc. (the “Company”) (Nasdaq: LI; HKEX: 2015), a leader in China’s new energy vehicle market, today announced that it is notifying holders of its 0.25% Convertible Senior Notes due 2028 (CUSIP No. 50202M AB8) (the “Notes”) that pursuant to the Indenture dated as of April 12, 2021 (the “Indenture”) relating to the Notes by and between the Company and Deutsche Bank Trust Company Americas, as trustee and paying agent, each holder has the right, at the option of such holder, to require the Company to purchase all of such holder’s Notes or any portion of the principal thereof that is equal to US$1,000 principal amount (or an integral multiple thereof) for cash on May 1, 2024 (the “Put Right”). The Put Right expires at 5:00 p.m., New York City time, on Monday, April 29, 2024. As required...

 The stenoparib Phase 2 monotherapy trial in advanced, recurrent ovarian cancer continues to show promise, prompting shift in resources to accelerate stenoparib development Further development of IXEMPRA® and dovitinib is de-prioritized The Company has been able to reduce costs materiallyBoston (March 27, 2024) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced a strategic pivot aimed at advancing its clinical-stage candidate stenoparib, a novel PARP/Tankyrase dual inhibitor, toward registration in advanced recurrent ovarian cancer, leveraging its DRP® platform to identify and enroll only the patients most likely to derive clinical benefit. This decision is the outcome of an extensive analysis of...

Restatement of non-cash items is not expected to materially impact cash position or operations DENVER, March 27, 2024 (GLOBE NEWSWIRE) — SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces that it will restate its financial statements for the fiscal year ended December 31, 2022 and for the interim periods ended March 31, 2023, June 30, 2023 and September 30, 2023. The restatement will impact the accounting treatment and classification of certain outstanding warrants and the prepaid forward purchase arrangement that was terminated in June 2023. Due to the additional audit procedures involved in the restatement, SeaStar Medical expects to file Form 12b-25 with the Securities and Exchange...

Decklar Resources Inc. and its co-venturer Millenium Oil & Gas Company Limited announce continued crude oil injection volumes from the Oza Oil Field through the Trans Niger Pipeline to the Bonny Export Terminal. Decklar and Millenium sell additional crude oil production from the Oza Oil Field to a local refinery in Edo State.CALGARY, Alberta, March 27, 2024 (GLOBE NEWSWIRE) — Decklar Resources Inc. (TSX-V: DKL) (OTC: DKLRF) (FSE: A1U1) (the “Company” or “Decklar”) and its co-venturer Millenium Oil & Gas Company Limited (“Millenium”) are pleased to announce ongoing crude oil injection volumes into the Trans Niger Pipeline (“TNP”) for transport to and export from the Bonny Export Terminal from the Oza Oil Field and continued sales to a local refinery in Edo State. Delivery of Crude Oil from the Oza Oil Field Decklar...

Revenues increased in more than 350% from its commercial contracts OMER, Israel, March 27, 2024 (GLOBE NEWSWIRE) — Odysight.ai Inc. (OTCQB: ODYS), a leading provider of visual based predictive maintenance (PdM) and condition-based monitoring (CBM) solutions, announced financial results for the year ended December 31, 2023 and the filing of its annual report on Form 10-K for such year with the U.S. Securities and Exchange Commission. As of December 31, 2023, Odysight.ai had $17.0 million of cash and short-term deposits on its balance sheet. Key highlights:The Company reported revenues of $3.0 million in the year ended of December 31, 2023, compared to $0.7 million in year ended on December 31, 2022, an increase of more than 350%.The Company achieved a positive gross profit for the first time. Gross profit was $0.5 million for...

ROCHESTER, N.Y., March 27, 2024 (GLOBE NEWSWIRE) — Vaccinex, Inc. (Nasdaq: VCNX) (“Vaccinex” or the “Company”), a clinical-stage biotechnology company pioneering a differentiated approach to treating Alzheimer’s disease and cancer through the inhibition of SEMA4D, today announced that it has entered into definitive agreements with certain institutional investors for the purchase and sale of 193,000 shares of its common stock in a registered direct offering together with warrants to purchase up to an aggregate of 193,000 shares of common stock in a concurrent private placement priced at-the-market under Nasdaq rules at a combined purchase price of $7.77 per share and accompanying warrant. The warrants will have an exercise price of $7.64 per share, will be immediately exercisable upon issuance and will expire 5 years from the initial...

CHICAGO, IL, March 27, 2024 (GLOBE NEWSWIRE) — via NewMediaWire — Epazz, Inc. (OTC Pink: EPAZ), a mission-critical provider of solid-state battery technology, drone technology, blockchain mobile apps and cloud-based business software solutions, has announced today that its subsidiary Galaxy Batteries, Inc., a trailblazer in solid-state battery technology, is proud to announce the opening of its new manufacturing site, a testament to the company’s unwavering commitment to innovation and sustainability. The new facility is in Sharjah City, United Arab Emirates, and represents a significant milestone for Galaxy Batteries, Inc., as it continues to lead the charge in developing products for the drone and aerospace market. “Our new manufacturing facility is to manufacture our solid state battery for drones and eVTOLs,” said Shaun...

Prana 2.0 Grand and Elite featuring the Company’s version 2.0 intelligent battery system extends on-road driving* range to 150km and 250km/charge; 2-4 times longer range than the average daily commute distanceSRIVARU Successfully Completes Road/Performance Testing2.0 INTELLIGENT BATTERY SYSTEM extends on-road driving* range to 150km and 250km/charge; 2-4 times longer range than the average daily commute distanceGRAND CAYMAN, Cayman Islands and COIMBATORE, India, March 27, 2024 (GLOBE NEWSWIRE) — SRIVARU Holding Limited (Nasdaq: SVMH; SVMHW) (“SRIVARU” or the “Company”), a prominent provider of premium electric motorcycles, today announced it has successfully completed on-road driving range tests of the Company’s new Prana 2.0 intelligent battery system. The Prana 2.0 intelligent battery system exceeded initial performance...